Health equity, a fundamental human right, remains elusive for many. As health communicators, we play a crucial role in addressing these disparities, bridging gaps and supporting underserved ...
A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...
Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...
Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...
GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...
The US Food and Drug Administration (FDA) has approved Shorla Oncology’s Imkeldi oral solution to treat certain forms of ...
COP29 President-Designate around November’s global climate conference. And reviewing the insights from a recent look at how ...
AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by ...
Ipsen has shared positive three-year results for Iqirvo (elafibranor) in patients with the rare cholestatic liver disease ...
The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback